Short Interest in HLS Therapeutics Inc. (OTCMKTS:HLTRF) Decreases By 96.9%

HLS Therapeutics Inc. (OTCMKTS:HLTRF) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 100 shares, a decrease of 96.9% from the March 15th total of 3,200 shares. Based on an average trading volume of 1,400 shares, the days-to-cover ratio is currently 0.1 days.

HLS Therapeutics Price Performance

OTCMKTS HLTRF traded down $0.33 during trading on Monday, reaching $2.96. 100 shares of the company’s stock were exchanged, compared to its average volume of 941. The business has a 50 day moving average price of $2.98 and a 200-day moving average price of $2.75. HLS Therapeutics has a fifty-two week low of $2.22 and a fifty-two week high of $3.56.

HLS Therapeutics Company Profile

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.